KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

AbbVie (ABBV) Acquisitions (2016 - 2025)

AbbVie has reported Acquisitions over the past 10 years, most recently at $204.0 million for Q1 2025.

Quarterly Acquisitions fell 97.78% to $204.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $204.0 million through Dec 2025, down 98.83% year-over-year, with the annual reading at $204.0 million for FY2025, 98.83% down from the prior year.
Acquisitions was $204.0 million for Q1 2025 at AbbVie, down from $8.3 billion in the prior quarter.
Over five years, Acquisitions peaked at $9.2 billion in Q1 2024 and troughed at $204.0 million in Q1 2025.
The 3-year median for Acquisitions is $4.4 billion (2021), against an average of $4.6 billion.
Year-over-year, Acquisitions surged 330.33% in 2021 and then tumbled 97.78% in 2025.
A 3-year view of Acquisitions shows it stood at $525.0 million in 2021, then surged by 1479.81% to $8.3 billion in 2024, then tumbled by 97.54% to $204.0 million in 2025.
Per Business Quant, the three most recent readings for ABBV's Acquisitions are $204.0 million (Q1 2025), $8.3 billion (Q3 2024), and $9.2 billion (Q1 2024).